Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor (Q45107803)

9 December 2017

Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor (English)

1 reference

9 December 2017

0 references

Streptococcus pneumoniae

1 reference

1 reference

Michael Kracht

9

0 references

Stefan Hippenstiel

14

object named as

Stefan Hippenstiel

1 reference

9 December 2017

13

Norbert Suttorp

1 reference

9 December 2017

1

Bernd Schmeck

1 reference

9 December 2017

7

Bastian Opitz

1 reference

9 December 2017

Janine Zahlten

2

1 reference

9 December 2017

Kerstin Moog

3

1 reference

9 December 2017

Vincent van Laak

4

1 reference

9 December 2017

Sylvia Huber

5

1 reference

9 December 2017

Andreas C Hocke

6

1 reference

9 December 2017

Elke Hoffmann

8

1 reference

9 December 2017

Jens Zerrahn

10

1 reference

9 December 2017

Sven Hammerschmidt

11

1 reference

9 December 2017

Simone Rosseau

12

1 reference

9 December 2017

language of work or name

English

0 references

publication date

13 October 2004

1 reference

Journal of Biological Chemistry

9 December 2017

1 reference

9 December 2017

279

1 reference

9 December 2017

53241-53247

1 reference

9 December 2017

51

1 reference

Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact

9 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

The pneumococcus at the millennium: not down, not out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Host innate defenses in the lung: the role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Marker discrimination in transformation and mutation of pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Adrenomedullin reduces endothelial hyperpermeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313702200

21 January 2018

Identifiers

DOI

10.1074/JBC.M313702200

1 reference

9 December 2017

1 reference